Xencor, Inc.
BISPECIFIC ANTIBODIES THAT BIND CD123 AND CD3
Last updated:
Abstract:
The present invention is directed to novel bispecific anti-CD123 x anti-CD3 antibodies.
Status:
Application
Type:
Utility
Filling date:
16 Dec 2020
Issue date:
20 May 2021